Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Akers Biosciences

(NASDAQ: AKER)
Add to Portfolio
+1.01 (+21.54%)
as of Apr 7, 2020

Values in US Thousands
  12-2019 12-2018 12-2017 12-2016
Sales $ 1,577 $ 1,666 $ 3,355 $ 2,961
Cost of Goods 1,098 1,538 2,406 1,083
Gross Profit 479 127 949 1,878
Operating Expenses 4,523 10,726 7,969 5,290
Operating Income -3,946 -10,060 -6,614 -3,329
Other Income/Expenses 58 -789 -753 25
Pre-tax Income -3,888 -10,849 -7,366 -3,304
Net Income from Cont. Operations -3,888 -10,849 -7,366 -3,304
Total Net Income $ -3,888 $ -10,849 $ -7,366 $ -3,304
Basic EPS from Cont. Ops. -6.34 -22.28 -150.77 -116.71
Basic EPS from Total Ops. -6.35 -22.28 -150.84 -117.03
Diluted EPS from Cont. Ops -6.34 -22.28 -150.77 -116.71
Diluted EPS from Total Operations -6.35 -22.28 -150.84 -117.03
EBITDA -3,872 -9,823 -6,343 -3,012